These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21301111)

  • 1. Incorporating parameter uncertainty into Quantitative Microbial Risk Assessment (QMRA).
    Donald M; Mengersen K; Toze S; Sidhu JP; Cook A
    J Water Health; 2011 Mar; 9(1):10-26. PubMed ID: 21301111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo.
    Schmidt PJ; Pintar KD; Fazil AM; Topp E
    Risk Anal; 2013 Sep; 33(9):1677-93. PubMed ID: 23311599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QMRA and decision-making: are we handling measurement errors associated with pathogen concentration data correctly?
    Schmidt PJ; Emelko MB
    Water Res; 2011 Jan; 45(2):427-38. PubMed ID: 20851444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards quantitative uncertainty assessment for cancer risks: central estimates and probability distributions of risk in dose-response modeling.
    Kopylev L; Chen C; White P
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):203-7. PubMed ID: 17905499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertainty distribution associated with estimating a proportion in microbial risk assessment.
    Miconnet N; Cornu M; Beaufort A; Rosso L; Denis JB
    Risk Anal; 2005 Feb; 25(1):39-48. PubMed ID: 15787755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.
    Hack CE
    Toxicology; 2006 Apr; 221(2-3):241-8. PubMed ID: 16466842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring heterogeneity in tumour data using Markov chain Monte Carlo.
    de Gunst MC; Dewanji A; Luebeck EG
    Stat Med; 2003 May; 22(10):1691-707. PubMed ID: 12720305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variance components analysis for pedigree-based censored survival data using generalized linear mixed models (GLMMs) and Gibbs sampling in BUGS.
    Scurrah KJ; Palmer LJ; Burton PR
    Genet Epidemiol; 2000 Sep; 19(2):127-48. PubMed ID: 10962474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Bayesian predictions of source water concentration for QMRA from presence/absence data for E. coli O157:H7.
    Petterson SR; Dumoutier N; Loret JF; Ashbolt NJ
    Water Sci Technol; 2009; 59(11):2245-52. PubMed ID: 19494465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for convergence in phylogenetic Markov chain Monte Carlo.
    Beiko RG; Keith JM; Harlow TJ; Ragan MA
    Syst Biol; 2006 Aug; 55(4):553-65. PubMed ID: 16857650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
    Jordan P; Brunschwig H; Luedin E
    Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gradient Markov chain Monte Carlo algorithm for computing multivariate maximum likelihood estimates and posterior distributions: mixture dose-response assessment.
    Li R; Englehardt JD; Li X
    Risk Anal; 2012 Feb; 32(2):345-59. PubMed ID: 21906114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the convergence of Markov Chain Monte Carlo methods: an example from evaluation of diagnostic tests in absence of a gold standard.
    Toft N; Innocent GT; Gettinby G; Reid SW
    Prev Vet Med; 2007 May; 79(2-4):244-56. PubMed ID: 17292499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data cloning: easy maximum likelihood estimation for complex ecological models using Bayesian Markov chain Monte Carlo methods.
    Lele SR; Dennis B; Lutscher F
    Ecol Lett; 2007 Jul; 10(7):551-63. PubMed ID: 17542934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascertainment correction for Markov chain Monte Carlo segregation and linkage analysis of a quantitative trait.
    Ma J; Amos CI; Warwick Daw E
    Genet Epidemiol; 2007 Sep; 31(6):594-604. PubMed ID: 17487893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferring an augmented Bayesian network to confront a complex quantitative microbial risk assessment model with durability studies: application to Bacillus cereus on a courgette purée production chain.
    Rigaux C; Ancelet S; Carlin F; Nguyen-thé C; Albert I
    Risk Anal; 2013 May; 33(5):877-92. PubMed ID: 22967223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Bayesian dynamic survival model in medicine.
    He J; McGee DL; Niu X
    Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying and reducing uncertainty in life cycle assessment using the Bayesian Monte Carlo method.
    Lo SC; Ma HW; Lo SL
    Sci Total Environ; 2005 Mar; 340(1-3):23-33. PubMed ID: 15752490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.
    Lambert PC; Sutton AJ; Burton PR; Abrams KR; Jones DR
    Stat Med; 2005 Aug; 24(15):2401-28. PubMed ID: 16015676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.